Evercore Wealth Management LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.6% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 386,969 shares of the healthcare conglomerate’s stock after selling 10,410 shares during the period. UnitedHealth Group comprises about 2.8% of Evercore Wealth Management LLC’s investment portfolio, making the stock its 2nd biggest holding. Evercore Wealth Management LLC’s holdings in UnitedHealth Group were worth $71,752,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of UNH. Blue Chip Partners Inc. acquired a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $110,000. Bruderman Asset Management LLC acquired a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in shares of UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares during the period. BDO Wealth Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $121,000. Finally, Kings Point Capital Management boosted its stake in shares of UnitedHealth Group by 27.9% during the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares during the period. 86.20% of the stock is owned by hedge funds and other institutional investors.
A number of equities research analysts have issued reports on UNH shares. Cowen reissued an “outperform” rating and set a $220.00 target price (up previously from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Morgan Stanley lifted their target price on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Jefferies Group reissued a “buy” rating and set a $215.00 target price on shares of UnitedHealth Group in a research note on Friday, August 18th. UBS reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Finally, Cantor Fitzgerald reissued a “buy” rating on shares of UnitedHealth Group in a research note on Tuesday, August 29th. Three research analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $224.56.
UnitedHealth Group Incorporated (NYSE:UNH) traded down $1.39 during trading on Friday, hitting $226.78. 3,326,053 shares of the stock were exchanged, compared to its average volume of 2,316,383. The company has a market cap of $219,765.23, a P/E ratio of 23.62, a P/E/G ratio of 1.68 and a beta of 0.65. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group Incorporated has a fifty-two week low of $156.09 and a fifty-two week high of $229.22.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the firm earned $2.17 EPS. equities research analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be issued a $0.75 dividend. The ex-dividend date is Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.32%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.
TRADEMARK VIOLATION NOTICE: This story was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.com-unik.info/2017/12/03/unitedhealth-group-incorporated-unh-is-evercore-wealth-management-llcs-2nd-largest-position.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
What are top analysts saying about UnitedHealth Group Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Incorporated and related companies.